Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma
- 21 April 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Brain Tumor Pathology
- Vol. 34 (2), 78-90
- https://doi.org/10.1007/s10014-017-0283-y
Abstract
Chordomas and chondrosarcomas are two major malignant bone neoplasms located at the skull base. These tumors are rarely metastatic, but can be locally invasive and resistant to conventional chemotherapies and radiotherapies. Accordingly, therapeutic approaches for the treatment of these tumors can be difficult. Additionally, their location at the skull base makes them problematic. Although accurate diagnosis of these tumors is important because of their distinct prognoses, distinguishing between these tumor types is difficult due to overlapping radiological and histopathological findings. However, recent accumulation of molecular and genetic studies, including extracranial location analysis, has provided us clues for accurate diagnosis. In this report, we review the genetic aberrations and molecular biology of these two tumor types. Among the abundant genetic features of these tumors, brachyury immunohistochemistry and direct sequencing of IDH1/2 are simple and useful techniques that can be used to distinguish between these tumors. Although it is still unclear why these tumors, which have such distinct genetic backgrounds, show similar histopathological findings, comparison of their genetic backgrounds could provide essential information.Keywords
This publication has 101 references indexed in Scilit:
- Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcomaNature Genetics, 2013
- From Notochord Formation to Hereditary Chordoma: The Many Roles ofBrachyuryBioMed Research International, 2013
- An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordomaThe Journal of Pathology, 2012
- Does insulin‐like growth factor 1 receptor (IGF‐1R) targeting provide new treatment options for chordomas? A retrospective clinical and immunohistochemical studyHistopathology, 2012
- Human Chondrosarcoma Cells Acquire an Epithelial-Like Gene Expression Pattern via an Epigenetic Switch: Evidence for Mesenchymal-Epithelial Transition during SarcomagenesisSarcoma, 2011
- Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomasNeuro-Oncology, 2010
- T (brachyury) gene duplication confers major susceptibility to familial chordomaNature Genetics, 2009
- Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathwayBritish Journal of Cancer, 2009
- Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationBritish Journal of Cancer, 2007
- Chromosome 7 abnormalities are common in chordomasCancer Genetics and Cytogenetics, 2005